FastWave Medical announces third utility patent for intravascular lithotripsy technology
FastWave Medical, a clinical-stage medical device company developing intravascular lithotripsy (IVL) technology, has announced the issuance of its third utility patent by the United States Patent and Trademark Office (USPTO).
The newly granted patent supports the differentiated design of FastWave’s next-generation IVL system, which aims to address challenges associated with treating calcified arteries in patients with occlusive vascular disease, a condition affecting millions of people worldwide. By developing advanced lithotripsy platforms, FastWave aims to solve the gaps with existing IVL technology while improving ease of use and patient safety by reducing procedural complications.
